The National Cancer Institute has made a substantial investment in new technology platforms for cancer proteomics, especially through the Mouse Models of Human Cancers and the Clinical Proteomic Technologies for Cancer. The proteome is critical to understanding functional genomics and systems biology of cancers and to discovery and validation of biomarker candidates and molecular targets for therapy and prevention. Sophisticated analysis of proteomes requires advanced informatics to deal with the complexity of specimens, the extreme dynamic range of protein concentrations, post-translational modifications, alternative splice isoforms, responses to all sorts of perturbations, and differences in databases. The current scarcity of trained scientists in this subdiscipline of bioinformatics is the focus of this proposed T32 training grant in Advanced Proteome Informatics of Cancer at the University of Michigan. We are building upon our successful experience with the Bioinformatics Graduate Program, based in the university-wide Center for Computational Medicine and Bioinformatics (CCMB). We now have 31 PhD and 6 M.S. students, plus 16 PhD and 14 M.S. graduates. Our faculty and students are in the leadership of Human Proteome Organization (HUPO) initiatives, development and global deployment of the Tranche distributed file-sharing system and the ProteomExchange, and creation of new algorithms for proteome informatics. We have a robust community of cancer researchers, bioinformaticians, statisticians, chemists, and software engineers focused on major challenges in proteome data analysis. Trainees will come from diverse backgrounds and will receive training in cancer biology, bioinformatics, and computer science through courses, seminars, journal club, and annual retreats. We have made substantial progress building strong relationships with sources of applicants from disadvantaged minority backgrounds. Establishment of an NCI training program in Advanced Proteome Informatics of Cancer at the U of M will provide a new pool of scientists well-equipped for independent careers in this field, enhance faculty research, and support NCI goals.

Public Health Relevance

Very large, complex datasets are being generated by cancer researchers using new proteomics technologies that allow them to study thousands of proteins simultaneously. This avalanche of data requires scientists well-trained in the specialized and multidisciplinary field of Proteome Informatics. Insufficient numbers of scientists are being trained in this rapidly growing field and this T32 proposes to address this issue.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA140044-03
Application #
8259223
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
2010-05-01
Project End
2015-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
3
Fiscal Year
2012
Total Cost
$102,545
Indirect Cost
$8,650
Name
University of Michigan Ann Arbor
Department
Biochemistry
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Hoesli, Rebecca; Birkeland, Andrew C; Rosko, Andrew J et al. (2018) Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma. Oral Oncol 77:83-89
Serio, J; Ropa, J; Chen, W et al. (2018) The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia. Oncogene 37:450-460
Ropa, James; Saha, Nirmalya; Chen, Zhiling et al. (2018) PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of Hoxa9 and Meis1 in acute myeloid leukemia. Oncotarget 9:22123-22136
Wu, Jiansheng; Zhang, Qiuming; Wu, Weijian et al. (2018) WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest. Bioinformatics 34:2271-2282
Grimley, Edward; Dressler, Gregory R (2018) Are Pax proteins potential therapeutic targets in kidney disease and cancer? Kidney Int 94:259-267
Tamura, Shuzo; Wang, Yin; Veeneman, Brendan et al. (2018) Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer. Bladder Cancer 4:77-90
Anwar, Talha; Arellano-Garcia, Caroline; Ropa, James et al. (2018) p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis. Nat Commun 9:2801
Mady, Ahmed S A; Liao, Chenzhong; Bajwa, Naval et al. (2018) Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening. Sci Rep 8:10210
Hawkins, Allegra G; Basrur, Venkatesha; da Veiga Leprevost, Felipe et al. (2018) The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling. Mol Cell Proteomics 17:901-912
Song, James M; Menon, Arya; Mitchell, Dylan C et al. (2017) High-Throughput Chemical Probing of Full-Length Protein-Protein Interactions. ACS Comb Sci 19:763-769

Showing the most recent 10 out of 41 publications